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Introduction
The Indian Psychiatric Society has embarked upon the task
of developing clinical practice guidelines (2003) which
culminated in the development of draft proposals following
a workshop (2004) at Jaipur which has already been
published as a supplement for extensive interaction and
review (2004). As a prelude to final acceptance and
publication, it is pertinent to look back at the history , its
current status and the future directions.
The beginning
The history of systematic efforts to identify empirically
validated treatments for mental disorder is only a few
decades old. Eysencks influential article on “The Effects
of Psychotherapy, An Evaluation”, is the first study to look
into methodological issues to distinguish effective from
ineffective mental health treatments. (Nathan & Gorman,
1998) This initial emphasis validating psychotherapy
research was important because “psychosocial
researchers” have had to deal with unavailability of a true
placebo control and the impossible nature of getting a
relevant double blind. This lacuna has been source of debate
whether and how to examine Psychotherapy outcomes
which are fundamentally different and they are good deal
more extensive than those in the history of
psychopharmacology outcome studies which dates back to
approximately 50 or so years. As it is, the failure of many
clinicians to attend to the research evidence on many
validated treatments is common to both psychosocial and
pharmacological treatments (Wilson, 1996). However,
research designs increasingly capable of discriminating
efficacious psychosocial and pharmacological treatments
have been developed. Assembling diagnostically
homogeneous patient groups became easy with the
appearance of diagnostic systems. Further to this, practice
guidelines, reflecting more potent outcome methodology and
more effective treatments have come into being. There
are differences in the standards of proof, methodological
criteria used for outcome studies and the degree to which
importance is accorded to clinical experience and judgement
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by different practice guidelines.
Why are clinical practice guidelines necessary?
The primary reason is to ensure that patients with psychiatric
illness receive the highest possible quality of care. Thus,
the guidelines specify the special training, knowledge, and
skills required to provide psychiatric treatment. Special
emphasis is placed on fundamental components of
psychiatric assessment (history taking; physical,
neurological, and mental status examination; laboratory and
neuroradiographic tests) as well as the process of
consultation systems analysis. Treatment issues receive
special attention as well and emphasize treatment
intervention based on a biopsychosocial model. The
importance of family and social assessment and intervention
in the treatment plan is also outlined. The last part of the
guidelines discuss special issues such as supervision
standards, ethical standards and research issues (Hayward
et al, 1995).
These guidelines outline the knowledge base and clinical
skills necessary to render quality care; and sets the basic
standards for the diagnostic evaluation, psychotherapeutic,
and pharmacologic treatment of this patient
population.These guidelines are not meant as a mandatory
set of imposed standards that the psychiatrist must follow.
The uniqueness and necessities of each individual clinical
situation is paramount. Ideally, guidelines should be based
on well-developed scientific evidence such as controlled
clinical studies. Because medicine is a continuously evolving
field, guidelines by their nature are a hybrid construction
from evidence based on scientific investigation and evidence
based on consensus opinions from clinicians. The Institute
of Medicine (IOM) has outlined the process of developing
guidelines that incorporates these principles. As the primary
goals of medicine are the prevention of disease and the
promotion of the health and well-being of the patient, these
guidelines will help meeting the ends by ensuring excellence
in the clinical care of patients with combined medical and
psychiatric illness (Gitlin et al, 1998).190
What  constitutes a good clinical guideline?
First, they define practice questions and explicitly identify
all their decision options and outcomes. Second, they
explicitly identify, appraise and summarize, in ways that
are most relevant to decision-makers, the best evidence
about prevention, diagnosis, prognosis, therapy, harm, and
cost-effectiveness. Third, they explicitly identify the decision
points at which this valid evidence needs to be integrated
with individual clinical experience in deciding on a course
of action (Sackett et al, 1997). Thus, the good ones don’t
tell you which decision to make, but identify the range of
potential decisions and provide you with the evidence which,
when added to your individual clinical judgment and your
patient’s values and expectations, will help to make our
own decision in the best interest of our patient.”
There are three questions that must be answered before
integrating “a guideline into the care of your patients,...for
that implementation requires changes in your behavior...”
“Are the recommendations in this guideline valid? Is this
valid guideline or strategy potentially useful (or important)?
And Should this guideline or strategy be applied in your
practice?”. A Good guidelines come from evidence-based
medicine (EBM), which is the conscientious, explicit and
judicious use of current best evidence in making decisions
about the care of individual patients (Stoudemire et al, 1998).
The five steps of EBM are: 1) convert clinical information
needs into answerable questions. 2) track down the best
evidence with which to answer them. 3) critically appraise
that evidence for its validity (closeness to the truth) and
usefulness (clinical applicability). 4) apply the results of this
appraisal in clinical practice and 5) evaluate your clinical
performance.
EBM can address each of the five clinical objectives of:
achieving a diagnosis, estimating a prognosis, deciding on
the best therapy, determining harm, and providing care of
the highest quality.
Guideline Development
There are three main methods of developing guidelines
(Woolf, 1990). Evidence Based Guidelines also describe
the strength of the evidence and try to separate opinion
from evidence. Consensus Guidelines is the most common
method of guideline development. Also known as global
subjective agreement of experts.  Persons and Beck (1998)
believe that consensus guidelines are a bad idea: according
to them, The consensus guideline is founded on expert
opinion and the experts can be wrong. The expert opinion
guideline methodology teaches clinicians to rely on experts,
not empirical findings and The expert opinion guideline does
not distinguish between clinical questions for which data
are available and clinical questions for which no data are
available.
The American Medical Association (AMA) attributes apply
to the development process, stating that practice
parameters/guidelines should 1) be developed by or in
conjunction with physician organizations, 2) explicitly
describe the methodology and process used in their
development, 3) assist practitioner and patient decisions
about appropriate health care for specific clinical
circumstances, 4) be based on current professional
knowledge and reviewed and revised at regular intervals,
and 5) be widely disseminated. The IOM’s attributes are
criteria for evaluating the finished product; these criteria
include 1) validity, based on the strength of the evidence,
expert judgment, and estimates of health and cost outcomes
compared with alternative practices; 2) reliability and
reproducibility; 3) clinical applicability and flexibility; 4)
clarity; 5) attention to multidisciplinary concerns; 6) timely
updates; and 7) documentation. Taken together, the IOM
and AMA prescriptives have essentially set international
standards for guideline efforts (American Psychiatric
Association(APA), 2001).
How practice guidelines are conceived?
They are part of a movement toward evidence-based
treatment, not as a treatment protocol demanding rigid
application. There are many limitations in all evidence-based
approaches-an insufficiency of evidence in many disorders;
the evidence is not equally relevant to clinicians, staffs, and
researchers; the techniques for integrating evidence are
often in an experimental stage; the evidence proffered
evades the issue of how to incorporate both social values
and individual preferences within an ongoing patient-
therapist relationship; and potential for misuse (there are
many procedures in medicine for which there is simply no
evidence, nor is there ever likely to be, that they work). In
choosing between Treatment A and Treatment B, for
instance, how does one balance (1) the proportion of
responders to each possible treatment, (2) the degree of
beneficial response, (3) the length of response, (4) the
likelihood of adverse effects with each treatment, (5) other
nonclinical costs, and (6) individual (or societal)
preferences?
Summary & Future Directions
The efforts to develop practice guidelines draw on a lengthy
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history of efforts to develop methodological guidelines for
outcome studies. Nathan & Gorman (1998) have analyzed
the outcome research of their day to identify strengths and
weaknesses and propose additional design features to make
future studies more sensitive and selective. In the Indian
context, as in the West, “What has been well known to
clinical scientists has been largely unknown” (Nathan &
Gorman, 1998) to practitioners and the public. As a
consequence, the best available data on the efficacy of
treatments have been neither widely taught nor widely
applied. With the availability of the draft proposals, this
situation seems destined to change. The growing interest
in the effectiveness and clinical utility of treatments, not
simply their efficacy represents an a additional impetus for
wider dissemination of these treatments beyond the clinical
research community to that of the practice community.
In this direction, the involvement and interaction of each
and every member of our  society by sharing their experience
and findings can enrich the proposals made in the guidelines.
The empirical data used at present been borrowed heavily
from Western studies and experience, much hard work
remains to develop more effective intervention and outcome
methodologies sensitive to our people, land and culture. The
draft proposals cover 5 common categories – Schizophrenia,
Depression, Bipolar Disorder, OCD and Anxiety & Panic
disorders. Efforts to increase the range and to have
guidelines on other categories in the coming days are
welcome developments. Once approved, it is hoped that
these guidelines would pave the way for reasonable
‘standards of care’ in mental health practice in varied
settings and contexts. All said and done, being a broad based
democratic exercise, it is hoped that it will stand the test of
time.
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